Can we predict who will benefit from tic therapy? new study aims to find out
NCT ID NCT06270251
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 30 people aged 12 to 21 with chronic tic disorders as they go through 8 sessions of CBIT, a well-established behavioral therapy. Researchers will track tic severity, controllability, and other factors to see what predicts a good response. The goal is to understand why only about half of people improve with CBIT and to find ways to boost its effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Comprehensive Behavioral Intervention for Tics (CBIT)
- What this could lead to
- If this study succeeds, it could reveal why some people improve with CBIT and others don't, pointing toward ways to make the therapy more effective.
- What could go wrong
- This is a small, early-stage observational study with only 30 participants, so findings may not apply to everyone. It is not testing a new treatment, just watching how an existing one works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC TIC DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55414, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wrist zap may tame tics: electrical pulses tested as Drug-Free option
- Brain training shows promise for tic control in teens
- Brain zap plus therapy may help teens tame tics
- Brain scans reveal why tourette patients are hypersensitive to everyday stimuli
- Teens with tics needed for landmark study on hidden symptoms